Get the Stockscreener App
2.27
3.65%
0.08
Biote Corp stock is traded at $2.27, with a volume of 153.25K.
It is up +3.65% in the last 24 hours and up +15.23% over the past month.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
See More
Previous Close:
$2.19
Open:
$2.18
24h Volume:
153.25K
Relative Volume:
0.58
Market Cap:
$68.85M
Revenue:
$188.16M
Net Income/Loss:
$18.43M
P/E Ratio:
5.0444
EPS:
0.45
Net Cash Flow:
$26.45M
1W Performance:
+0.00%
1M Performance:
+15.23%
6M Performance:
-14.34%
1Y Performance:
-42.24%
1-Day Range:
$2.16
$2.30
1-Week Range:
$2.12
$2.50
52-Week Range:
$1.27
$4.7498
Biote Corp Stock (BTMD) Company Profile
Name
Biote Corp
Sector
Industry
Phone
972-486-9346
Address
1875 W. WALNUT HILL LN #100, IRVING
Compare BTMD vs MOBBW, SHMD, GOODO, PSNYW, DWLD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BTMD
Biote Corp. Class A Common Stock
|
5.89 | 33.33M | 0 | 0 | 0 | 0.00 |
MOBBW
Mobilicom Limited Warrants
|
2.33 | 3.33B | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
6.79 | 397.06M | 52.15M | -21.46M | 0 | -0.4675 |
GOODO
Gladstone Commercial Corporation
|
20.25 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.77 | 254.39M | 2.07B | -1.42B | -1.37B | -0.6765 |
DWLD
Davis Select Worldwide ETF
|
46.74 | 0 | 0 | 0 | 0 | 0.00 |
Biote Corp Stock (BTMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-25 | Downgrade | B. Riley Securities | Buy → Neutral |
| Dec-16-24 | Initiated | Craig Hallum | Buy |
| Feb-20-24 | Initiated | B. Riley Securities | Buy |
| Feb-01-24 | Initiated | Jefferies | Buy |
| Jun-24-22 | Initiated | Cowen | Outperform |
| Jun-23-22 | Initiated | ROTH Capital | Buy |
View All
Biote Corp Stock (BTMD) Latest News
biote Corp. (BTMD) director receives 130,000 stock options at $2.34 strike - Stock Titan
biote Corp. (BTMD) Executive Chairman receives 114,157 stock options at $2.34 - Stock Titan
Biote Corp. (BTMD) Holds Steady at $2.34: Consolidation or Calm Before the Next Move?Hot Stock Picks - newsline.com
Biote Corp. Q1 2026 Earnings: EPS Beat Drives Cautious Optimism Amidst Flat Revenue DisclosureLong-Term Guidance - newsline.com
How The Evolving Story For biote (BTMD) May Shape Future Investor Expectations - Yahoo Finance
Biote Corp. (BTMD) Slides Toward Key Support Level as Selling Pressure PersistsFactor Rotation - newsline.com
Biote Appoints Bob Peterson as Interim CEO, Reaffirms 2026 Financial Guidance Amid Leadership Transition - Minichart
Biote (NASDAQ: BTMD) names interim CEO, appoints Executive Chairman and reaffirms 2026 outlook - Stock Titan
Biote appoints Bajaj as Chief Medical Officer - TipRanks
Biote Corp. (BTMD) Q1 2026 Earnings: EPS Beat Drives 4.5% Stock UptickEBITDA Analysis - The Legal Advocate
Biote names Komal Bajaj as chief medical officer - Investing.com
Biote names Komal Bajaj as chief medical officer By Investing.com - Investing.com South Africa
NYC hospital quality chief Komal Bajaj becomes Biote CMO - Stock Titan
Biote Corp. Q1 2026 Earnings: EPS Beats Estimates but Stock Declines Amid Revenue Uncertainty - newsline.com
BTMD Q1 2026 Earnings: EPS Surprises by 23.7% Despite Negative Stock ReactionStrong Earnings Momentum - newsline.com
CEO out after year leading hormone therapy company Biote - The Business Journals
BTMD Q1 2026 Earnings: EPS Surpasses Estimates Amid Missing Revenue DetailsPost-Earnings Drift - newsline.com
Bob Peterson Named Interim CEO of Biote Corp., Effective May 28, 2026 - geneonline.com
Biote Names Its Chief Financial and Business Officer as Interim CEO - Dallas Innovates
Biote names CFO Bob Peterson as interim CEO, reaffirms FY26 outlook amid leadership shift - MSN
Biote announces Christensen to step down as CEO, Peterson named interim CEO - TipRanks
Biote names Bob Peterson interim CEO as Christensen steps down - Investing.com UK
Biote Announces Management Changes - marketscreener.com
Biote Announces Chief Executive Officer Changes - marketscreener.com
Biote Reaffirms Earnings Guidance for the Full Year 2026 - marketscreener.com
Biote names Bob Peterson as interim CEO - marketscreener.com
Biote names Bob Peterson interim CEO as Christensen steps down By Investing.com - Investing.com Australia
Biote Board Retained Executive Search Firm to Assist With Identification, Evaluation of CFO Candidates >BTMD - Moomoo
Biote CEO steps down for family reasons as CFO Bob Peterson takes interim helm - Stock Titan
BTMD Q1 2026 Earnings: EPS Beats Estimates by 23.71% Amid Revenue DiscrepancyStrong Earnings Momentum - newsline.com
Number of shareholders of Biote Corp. – NASDAQ:BTMD - TradingView
Biote Corp. (BTMD) Declines 3.86%, Approaches Critical Support at $1.89Vanna Flow - newsline.com
Biote Corp. (BTMD) Extends Decline: Down 3.86% as Support Level Comes into FocusSpring Pattern - The Legal Advocate
BTMD Q1 2026 Earnings: Biote Corp. Beats EPS Estimates, Stock Declines SlightlyEarnings Call Highlights - Newser
biote shareholders elect directors and ratify Deloitte appointment - TipRanks
biote Corp. (NASDAQ: BTMD) investors back board nominees and Deloitte as 2026 auditor - Stock Titan
Biote maintains 2026 outlook above $190M revenue as it targets restoring Asteria supply by end of Q2 - MSN
BTMD SEC FilingsBiote 10-K, 10-Q, 8-K Forms - Stock Titan
biote Corp. (BTMD) director Andrew Heyer receives options and 35,259 deferred RSUs - Stock Titan
Dow Theory LettersBiote Corp.Class A common stock (Nasdaq:BTMD) Stock Quote - FinancialContent
biote (BTMD) director awarded 130,000 options and deferred RSUs - Stock Titan
biote Corp. (BTMD) grants options and RSUs to director - Stock Titan
biote (BTMD) director receives 130,000 options and 37,777 deferred RSUs - Stock Titan
biote Corp. (BTMD) director receives 195,000 stock options at $2.20 strike - Stock Titan
biote Corp. (BTMD) director Barrera receives 121,452 stock options at $2.20 - Stock Titan
Bandera Partners reports 2.07M shares in biote Corp. (BTMD) - Stock Titan
BTMD PE Ratio & Valuation, Is BTMD Overvalued - Intellectia AI
Earnings call transcript: Biote Corp reports Q1 2026 earnings miss amid recall impact By Investing.com - Investing.com South Africa
Earnings call transcript: Biote Corp reports Q1 2026 earnings miss amid recall impact - Investing.com Nigeria
TradingKey - TradingKey
Pellet recall and lower revenue pressure biote Corp (NASDAQ: BTMD) in Q1 2026 - Stock Titan
Biote Corp Stock (BTMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.28%
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):